AnaptysBio Inc.

NASDAQ: ANAB · Real-Time Price · USD
19.79
-0.23 (-1.15%)
At close: Aug 19, 2025, 10:24 AM

AnaptysBio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
123.08M 35.97M 71.31M 495.73M
Short-Term Investments
262.29M 354.94M 369.93M 52.37M
Long-Term Investments
35.47M 27.03M 142.94M 67.1M
Other Long-Term Assets
256K 256K 256K 256K
Receivables
40.77M 6.85M 1.42M 876K
Inventory
n/a n/a n/a n/a
Other Current Assets
5.74M 9.08M 4.54M n/a
Total Current Assets
431.88M 406.83M 447.2M 553.88M
Property-Plant & Equipment
16.23M 18.27M 19.99M 21.84M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
51.96M 45.55M 163.18M 89.19M
Total Assets
483.83M 452.39M 610.38M 643.07M
Account Payables
4M 4.7M 2.78M 1.74M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 1.64M 1.5M
Other Current Liabilities
39.5M 23.77M 14.62M 7.17M
Total Current Liabilities
45.43M 37.44M 26.05M 16.1M
Long-Term Debt
353.43M n/a n/a n/a
Other Long-Term Liabilities
n/a 310.81M 304.41M 251.09M
Total Long-Term Liabilities
367.54M 326.84M 322.23M 270.54M
Total Liabilities
412.97M 364.29M 348.28M 286.64M
Total Debt
16.04M 17.81M 19.45M 20.95M
Common Stock
30K 27K 29K 28K
Retained Earnings
-759.33M -614.1M -450.48M -321.75M
Comprehensive Income
305K -797K -5.25M -422K
Shareholders Equity
70.87M 88.1M 262.1M 356.43M
Total Investments
297.76M 381.96M 512.87M 119.47M